Drug Manufacturers - General Industry

Members of Parliament invested in the Drug Manufacturers - General Industry

52 investments

11 companies

Investors

Filed	Name	Company	Pur. £	Cur. £	P/L %	MPV*
Apr '12	Lord Glendonbrook	Astrazeneca / LSE:AZN.L	£2,666.50	£10,444.00	291.67%	£274,172.14
Apr '10	Baroness Noakes	Astrazeneca / LSE:AZN.L	£2,938.00	£10,444.00	255.48%	£248,835.94
Mar '14	Viscount Eccles	Astrazeneca / LSE:AZN.L	£3,876.50	£10,444.00	169.42%	£188,592.80
Dec '16	Lord Burns	Astrazeneca / LSE:AZN.L	£4,116.00	£10,444.00	153.74%	£177,619.05
Feb '11	Lord Wasserman	Johnson & Johnson / NYQ:JNJ	£60.93	£154.93	154.28%	£177,992.77
Jan '13	Lord Sassoon	Johnson & Johnson / NYQ:JNJ	£72.69	£154.93	113.14%	£149,196.58
May '11	Lord Glendonbrook	Novartis / NYQ:NVS	£54.04	£111.17	105.71%	£143,999.34
Sep '16	Lord Gadhia	Astrazeneca / LSE:AZN.L	£5,099.00	£10,024.00	96.59%	£137,611.30**
May '18	Lord Grabiner	Astrazeneca / LSE:AZN.L	£5,417.00	£10,444.00	92.80%	£134,960.31
Apr '17	Lord Donoughue	Novartis / NYQ:NVS	£66.05	£111.17	68.32%	£117,821.20
Aug '14	Lord Carter of Coles	Johnson & Johnson / NYQ:JNJ	£100.16	£161.55	61.29%	£112,904.35**
Feb '21	Lord Etherton	Astrazeneca / LSE:AZN.L	£7,422.00	£10,444.00	40.72%	£98,501.75
Nov '23	Lord Mance	Eli Lilly Co / VIE:LLYC.VI	£557.00	£747.60	34.22%	£93,953.32
May '20	Lord Deighton	Astrazeneca / LSE:AZN.L	£8,361.00	£11,236.00	34.39%	£94,070.09**
Jun '21	Lord Morse	Astrazeneca / LSE:AZN.L	£8,005.00	£10,444.00	30.47%	£91,327.92
Apr '21	Baroness Deech	Novartis / NYQ:NVS	£88.38	£111.17	25.79%	£88,050.47
Jul '16	Lord Lloyd-Webber	Johnson & Johnson / NYQ:JNJ	£122.64	£154.93	26.33%	£88,430.36
Apr '24	Lord Mendoza	Eli Lilly / NYQ:LLY	£731.33	£859.73	17.56%	£82,289.93
Aug '17	Lord Sterling of Plaistow	Johnson & Johnson / NYQ:JNJ	£133.45	£157.98	18.38%	£82,866.99**
May '11	Lord Glendonbrook	Pfizer / NYQ:PFE	£19.54	£22.78	16.55%	£81,587.79
Apr '21	Lord Farmer	Glaxosmithkline / NYQ:GSK	£36.65	£40.88	11.54%	£78,079.12**
May '24	Lord Goldsmith	Abbvie / NYQ:ABBV	£160.81	£180.37	12.16%	£78,514.39
Apr '23	Lord Grabiner	Novartis / NYQ:NVS	£95.80	£107.52	12.23%	£78,563.67**
Oct '20	Lord Taverne	Glaxosmithkline / NYQ:GSK	£37.57	£40.95	9.00%	£76,297.58**
Jan '24	Lord Fink	Roche / EBS:ROG.SW	£251.85	£262.30	4.15%	£72,904.50
May '23	Lord Leitch	Astrazeneca / LSE:AZN.L	£11,820.00	£12,340.00	4.40%	£73,079.53**
Apr '17	Lord Leigh of Hurley	Roche / EBS:ROG.SW	£255.80	£262.30	2.54%	£71,778.73
Nov '23	Lord Mance	Astrazeneca / LSE:AZN.L	£10,230.00	£10,444.00	2.09%	£71,464.32
Dec '16	Lord Burns	Glaxosmithkline / NYQ:GSK	£37.39	£37.50	0.29%	£70,205.94
Mar '25	Lord Fink	Johnson & Johnson / NYQ:JNJ	£161.72	£154.93	-4.20%	£67,060.97
Apr '10	Baroness Noakes	Glaxosmithkline / NYQ:GSK	£39.49	£37.50	-5.04%	£66,472.52
Apr '10	Lord Levene of Portsoken	Glaxosmithkline / NYQ:GSK	£39.38	£37.50	-4.77%	£66,658.20
May '23	Lord Fink	Johnson & Johnson / NYQ:JNJ	£165.03	£154.93	-6.12%	£65,715.93
Feb '25	Lord Green of Hurstpierpoint	Roche / EBS:ROG.SW	£285.70	£262.30	-8.19%	£64,266.71
Mar '17	Lord Lloyd-Webber	Glaxosmithkline / NYQ:GSK	£42.31	£37.50	-11.37%	£62,042.07
May '23	Lord Fink	Astrazeneca / LSE:AZN.L	£11,774.00	£10,444.00	-11.30%	£62,092.75
May '23	Lord Londesborough	Astrazeneca / LSE:AZN.L	£11,924.00	£10,444.00	-12.41%	£61,311.64
May '11	Lord Glendonbrook	Glaxosmithkline / NYQ:GSK	£42.78	£37.50	-12.34%	£61,360.45
Jan '20	Lord Gadhia	Glaxosmithkline / NYQ:GSK	£46.50	£40.95	-11.94%	£61,645.16**
Mar '25	Lord Fink	Roche / EBS:ROG.SW	£303.00	£262.30	-13.43%	£60,597.36
Apr '24	Lord Balfe	Astrazeneca / LSE:AZN.L	£12,024.00	£10,444.00	-13.14%	£60,801.73
May '23	Lord Reay	Sanofi / NMS:SNY	£55.11	£47.22	-14.32%	£59,978.23**
Apr '22	Lord Cromwell	Johnson & Johnson / NYQ:JNJ	£179.90	£154.37	-14.19%	£60,066.15**
May '24	Lord Goldsmith	Astrazeneca / LSE:AZN.L	£12,156.00	£10,444.00	-14.08%	£60,141.49
Apr '21	Lord Grabiner	Roche / EBS:ROG.SW	£309.65	£262.30	-15.29%	£59,295.98
May '24	Lord Balfe	Glaxosmithkline / NYQ:GSK	£44.02	£37.50	-14.81%	£59,631.99
Jan '13	Lord Sassoon	Glaxosmithkline / NYQ:GSK	£44.75	£37.50	-16.20%	£58,659.22
Aug '16	Lord Lloyd-Webber	Eli Lilly / NYQ:LLY	£80.55	£67.15	-16.64%	£58,355.06**
Aug '20	Lord Reay	Roche / EBS:ROG.SW	£315.05	£249.80	-20.71%	£55,502.30**
Feb '16	Lord Lloyd-Webber	Pfizer / NYQ:PFE	£29.02	£22.78	-21.51%	£54,943.07
Mar '14	Baroness Eccles of Moulton	Glaxosmithkline / NYQ:GSK	£53.43	£37.50	-29.81%	£49,129.70
Jul '18	Lord Glendonbrook	Bayer / GER:BAYN.DE	£95.26	£22.48	-76.40%	£16,519.00

Showing 1 to 52 of 52 entries

* Minimum Potential Value based on £70,000.00 invested at time of declaration.

** Interest ceased/exited on filed date.